Research offers new hope for treatment of rare genetic disease

July 28, 2014 by Charlotte Anscombe, University of Nottingham

New research by experts at The University of Nottingham could offer new clues for the treatment of a rare genetic disease.

TRAPS (TNF Receptor Associated Periodic Syndrome) was first identified in Nottingham more than 30 years ago and causes periodic, spontaneous flares of fever, rashes, muscle pains and other symptoms without any other apparent cause.

The new research, published in The European Journal of Immunology, provides the most complete picture to date of the changes that happen inside the cells of TRAPS patients that trigger the attacks of fever and inflammation that occur in the .

Dr Lucy Fairclough, of the University's School of Life Sciences, was among a team of immunology researchers who led the study. She said: "TRAPS has a serious effect on the lives of its sufferers—imagine having symptoms similar to flu, with those symptoms appearing every few weeks and possibly lasting several weeks, and this happens life-long."

"Fortunately, the research that has led to improved understanding of TRAPS has also led to better therapies for the disease that can greatly improve the quality of life for patients. However, these therapies are treating the consequences of the disease rather than the processes inside cells of the body that are driving the disease.  In the latest study we provide the most complete picture to date of the changes that happen inside the cells of TRAPS patients that trigger the attacks of fever and inflammation.  This opens new avenues for trying to block these disease-causing processes at their source, with the hope of better therapies for TRAPS."

TRAPS was first described in a research article published in The Quarterly Journal of Medicine in 1982 by Williamson and colleagues who worked at Nottingham University Hospitals NHS Trust and the University's Medical School.

At the time, these doctors gave the disease the name 'Familial Hibernian Fever' because all patients were members of the same family originating from Ireland (Hibernia being the Roman name for Ireland).

In the late 1990s, it was found that this is a genetic disease affecting what's called TNF Receptor 1 and the name of the disease was changed to TRAPS in recognition of this fact. It is now known that TRAPS affects thousands of people in many different families around the world.

This latest study, which also involved academics from Mansoura University in Egypt, the German Cancer Research Centre in Heidelberg, Germany, and Nottingham University Hospitals NHS Trust, opens new avenues for trying to block these disease-causing cell changes at their source, with the hope of better therapies for not only for TRAPS but for other diseases of this type.

Explore further: Study shows benefits, limits of therapy for rare inflammatory syndrome

Related Stories

Study shows benefits, limits of therapy for rare inflammatory syndrome

October 26, 2011
(Medical Xpress) -- A study shows that the medication etanercept reduces the frequency and severity of symptoms of TNF receptor-associated periodic syndrome (TRAPS), a rare inherited condition characterized by recurrent fevers, ...

Expelled DNA that traps toxins may backfire in obese

June 18, 2013
(Medical Xpress)—The body's most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight and others at risk for cancer, diabetes and chronic inflammation, suggests ...

Stimulating a protein in skin cells could improve psoriasis symptoms

June 5, 2014
Psoriasis is a common, long-lasting disease that causes itchy or sore patches of thick, red skin with silvery scales. Environmental contaminants can trigger psoriasis and other autoimmune disorders, and it is thought that ...

New prognostic test for breast cancer could improve patient treatment

March 11, 2014
A study by researchers in Nottingham has developed a new clinical test for breast cancer which aims to improve patient treatment.

Recommended for you

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

Immunosuppressive cells in newborns play important role in controlling inflammation in early life

January 15, 2018
New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing ...

Memory loss from West Nile virus may be preventable

January 15, 2018
More than 10,000 people in the United States are living with memory loss and other persistent neurological problems that occur after West Nile virus infects the brain.

Mould discovery in lungs paves way for helping hard to treat asthma

January 15, 2018
A team at The University of Manchester have found that in a minority of patients they studied, a standard treatment for asthma—oral steroids—was associated with increased levels of the treatable mould Aspergillus in the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.